Olon Group announces the next strategic milestone of Olon Ricerca Bioscience. A new line to produce Highly Potent APIs.
“Now, we can take clients from pre-clinical to phase II and then, if the project is successful, transfer the technology to our European sites for phase III/commercial. We offer our customers a full partnership from preclinical up to commercial” commented ORB CEO Luigi Trussardo
Milano, October 22nd, 2021 – Olon Group is
pleased to announce the next strategic development milestone of Olon Ricerca
Bioscience, the campus located in Ohio (US), mostly focused on R&D. The
latest investments for Olon Ricerca Bioscience (ORB) are to set up a new line
to produce highly potent APIs (HPAPIs).
So Olon, that has
years of expertise in HPAPIs, makes ORB be aligned with that technology, to
bring on clients that need HPAPIs in clinical phases, as early as possible. In
the near future the company could offer HPAPIs for early clinical phases and
then transfer programs to the European sites for later-phase clinical and
beyond.
ORB campus has
officially begun the investment in HPAPI capabilities. Over the long term, the
plan is to increase its capacity to meet demand up to a hundred grams and bring
U.S. site to mirror the capacity of the Italian facilities, which includes
multiple sites that can perform the production of HPAPIs on a larger scale.
ORB has also
expanded its capacity, closing the gap between preclinical phase and commercial
production, where it already played, adding on capabilities for the initial development
of new chemical entities (NCEs).
“Now, we can take
clients from pre-clinical to phase II and then, if the project is successful,
transfer the technology to our European sites for phase III/commercial. We
offer our customers a full partnership from preclinical up to commercial.
Although we don’t carry out production from start to finish of the API
development at the same site, our customers appreciate the fact that their
program can be completed through a single provider. Up to know we have already
several examples demonstrating the smooth technological transfer of processes
and analytics between the two side of the oceans within the same quality and
operational system” commented Luigi Trussardo, CEO of Olon
Ricerca Bioscience.
Olon Ricerca is in northeast Ohio, 30 miles east of Cleveland. The
campus consists of two buildings and is divided into four operation
departments.
ORB relies on an analytical department that provides a
comprehensive range of on-site analytical chemistry services to fully support
the drug development process, from preclinical to post-marketing phases. It has
decades of experience conducting studies in compliance with the US FDA–
GLP/cGMP regulatory requirements and the International Conference on Harmonization
(ICH), providing this offering as a standalone business. The synthetic
chemistry group is comprised of 20 people who are providing services supporting
the discovery phase (early-stage scaffold/analog synthesis, lead optimization,
preclinical compound synthesis support to acute/tox studies), with preparation
of mg to 1 kg amounts for active ingredients and advanced intermediates, as
well as metabolites/Impurities and reference standards. ORB then has the two
groups that are more dedicated to GMP — process chemistry and process
development & manufacturing. Process chemistry includes the chemists that
support the progression of drug candidates and specialty materials through all
phases of development and manufacture. In process development and manufacturing,
ORB produces API and intermediates.
www.olonspa.com
/ olonricerca.com / [email protected] /
Media contact
Sabrina Spina
[email protected]
– mobile 338.6674289
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance